Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives

L Ceolin, MA da Silveira Duval… - Endocrine-related …, 2019 - erc.bioscientifica.com
Medullary thyroid carcinoma (MTC) is a rare type of tumor that originates from thyroid C cells
and accounts for 2–4% of all malignant thyroid neoplasms. MTC may occur sporadically or …

Multiple endocrine neoplasia type 2: A review

JS Mathiesen, G Effraimidis, M Rossing… - Seminars in cancer …, 2022 - Elsevier
Multiple endocrine neoplasias are rare hereditary syndromes some of them with malignant
potential. Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant hereditary …

Overview of the 2022 WHO classification of familial endocrine tumor syndromes

V Nosé, A Gill, JMC Teijeiro, A Perren, L Erickson - Endocrine pathology, 2022 - Springer
This review of the familial tumor syndromes involving the endocrine organs is focused on
discussing the main updates on the upcoming fifth edition of the WHO Classification of …

Advances in the management of MEN2: from improved surgical and medical treatment to novel kinase inhibitors

SA Wells - Endocrine-Related Cancer, 2018 - erc.bioscientifica.com
Medullary thyroid carcinoma (MTC), a tumor derived from the neural crest, occurs either
sporadically or as the dominant component of the type 2 multiple endocrine neoplasia …

GLOBAL ENDOCRINOLOGY: Geographical variation in the profile of RET variants in patients with medullary thyroid cancer: a comprehensive review

RMB Maciel, AL Maia - European Journal of Endocrinology, 2022 - academic.oup.com
Genetic variability in humans is influenced by many factors, such as natural selection,
mutations, genetic drift, and migrations. Molecular epidemiology evaluates the contribution …

Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations

ZX Wang, QQ Li, J Cai, JZ Wu, JJ Wang… - Journal of Medicinal …, 2024 - ACS Publications
Over the past decades, the role of rearranged during transfection (RET) alterations in
tumorigenesis has been firmly established. RET kinase inhibition is an essential therapeutic …

[HTML][HTML] Dermatologic manifestations of endocrine disorders

R Raj, G Elshimy, R Mishra, N Jha, V Joseph… - Cureus, 2021 - ncbi.nlm.nih.gov
Endocrine disorders are known to involve all organ systems of the body, including the skin.
The cutaneous manifestations of endocrine disorders can range from common findings such …

Primary Localized Cutaneous Amyloidosis in Central Europe: A Retrospective Monocentric Study on Epidemiology and Therapy

S Pálla, E Kuroli, EA Tóth, B Hidvégi, P Holló… - Journal of Clinical …, 2023 - mdpi.com
Amyloid deposits can be the cause of many chronic diseases. Primary localized cutaneous
amyloidosis (PLCA) is a chronic dermatologic condition with amyloid deposits in the …

Primary localized cutaneous amyloidosis of keratinocyte origin: an update with emphasis on atypical clinical variants

L Hamie, I Haddad, N Nasser, M Kurban… - American Journal of …, 2021 - Springer
Amyloid is a protein derived from at least 20 different substances. Once misfolded, it results
in a group of cutaneous and systemic conditions. Primary localized cutaneous amyloidosis …

Advances and controversies in the management of medullary thyroid carcinoma

AL Maia, SM Wajner, CVF Vargas - Current opinion in oncology, 2017 - journals.lww.com
Tyrosine kinase inhibitors are effective therapeutic agents for the treatment of progressive
MTC. Nevertheless, it is not clear who will benefit the most from therapy, and the decision …